Evelo Biosciences Reports First Quarter Financial Results and Business Highlights

NEXT STORY
Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer
PREV STORY
Paratek Pharmaceuticals Announces First Quarter 2020 Total Revenues of $7.9 Million including NUZYRA® (omadacycline) Net Sales of $7.3 Million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Companion Diagnostics Market to Reach a New Threshold of Growth: Expected to Reach USD 7.8 Billion in 2027

author_avatar
NASDAQ Market News

Reliq Health Technologies, Inc. Provides Corporate Update and Overview of Expanded CMS Coverage for Remote Patient Monitoring for 2022

author_avatar
NASDAQ Market News

$4.31 Billion Worldwide Hematology Analyzers and Reagents Industry to 2030 – Identify Growth Segments for Investment

author_avatar
NASDAQ Market News